WuXi AppTec Signs Dual MoUs with NEOM and Saudi Ministry of Health to Advance Localized Drug Development
WuXi AppTec Co., Ltd. (SHA: 603259, HKG: 2359) today announced the signing of strategic Memoranda of...
Deals
Qyuns Therapeutics Partners with Roche for Global Rights to Long‑Acting Bispecific Antibody QX031N
Qyuns Therapeutics Co., Ltd. (HKG: 2509) today announced a global exclusive collaboration and licensing agreement with F. Hoffmann‑La...
Fosun Pharmaceutical Announces Spin‑Off and HK Listing of Adgenvax
Fosun Pharmaceutical (Group) Co., Ltd. (SHA: 600196, HKG: 2196) today disclosed its intention to spin‑off...
Fosun Pharma Target Fund Launches with RMB 1 Billion Capital, Led by China Resources GP
Fosun Pharmaceutical (Group) Co., Ltd. (SHA: 600196, HKG: 2196) announced today that its controlled subsidiary,...
PolyMed Biopharmaceuticals Completes Pre‑A++ Funding Round Led by Caleb Capital, Fuels PROTAC‑Focused Pipeline
PolyMed Biopharmaceuticals Co., Ltd., a Chinese‑based, internationally‑oriented biopharma innovator, announced the successful closure of its...
Novartis Strikes USD 12b Deal for Avidity’s RNA Therapeutics and Gene-Targeted Pipeline
Novartis (NYSE: NVS) announced an agreement to acquire San Diego-based biotech Avidity Biosciences for USD...
Eli Lilly to Acquire Adverum Biotechnologies for Up to USD 261.7m for Ixo-vec Access
Eli Lilly (NYSE: LLY) announced on October 24, 2025, that it will acquire gene therapy...
AstraZeneca Launches Sixth Global R&D Center in Beijing to Accelerate China Investments
AstraZeneca (AZ, NASDAQ: AZN) announced on October 25, 2025, the launch of its sixth Global...
Chugai to Acquire Renalys Pharma for JPY 31 Billion to Expand IgA Nephropathy Treatment Portfolio
Chugai Pharmaceutical, a member of the Roche Group, announced on October 24, 2025, that it...
Novartis Transfers Lucentis and Beovu Rights to CMS Vision in China Deal
Novartis (NYSE: NVS) announced on October 27, 2025, the signing of a strategic cooperation agreement...
GSK Secures Global Rights to Syndivia’s ADC for Metastatic Prostate Cancer
British pharmaceutical giant GlaxoSmithKline (GSK, NYSE: GSK) and Syndivia announced on October 27, 2025, that...
Eli Lilly Partners with Cipla to Distribute New Tirzepatide Brand “Yurpeak” in India
Eli Lilly and Company (India) Pvt. Ltd. (Lilly) and Cipla Limited (BOM: 500087, NSE: CIPLA) today announced a...
Pfizer R&D & ATLATL Forge Open Innovation Partnership in Beijing
Pfizer’s R&D Open Innovation Center and ATLATL Innovation Center announced a strategic cooperation agreement, creating...
Fosun Pharma & Helsinn Partner to Produce Fosnetupitant for Akynzeo in China
Fosun Pharma (SHA: 600196, HKG: 2196) and the Helsinn Healthcare SA announced a strategic cooperation...
Innovent and Takeda Forge $11.4 B Partnership on IBI363, IBI343 & IBI3001 ADC Therapies
Innovent Biologics, Inc. (HKG: 1801) today announced a landmark global strategic collaboration with Takeda Pharmaceutical...
Rani Therapeutics and Chugai Forge $1.085 Billion Collaboration Deal for Innovative Oral Therapeutic
Rani Therapeutics Holdings, Inc. today announced a comprehensive Collaboration and License Agreement with Japan’s Chugai...
Boston Scientific Announces Nalu Medical Acquisition to Expand Chronic‑Pain Portfolio
Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement...
Accord Plasma Completes Acquisition of Prothya Biosolutions, Expanding European Plasma‑Derived Medicinal Product (PDMP) Capabilities
Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, announced today that it has successfully completed...
Advaccine Biotechnology Announces Private Placement of Up to 2.2 Million Shares to Raise RMB 300 Million for Microneedle & Vaccine Development
Advaccine Biotechnology (NEEQ: 874055) today disclosed a private placement offering of no more than 2,203,200 shares...
Samsung Bioepis Announces Global ADC Collaboration with Phrontline Biopharma to Advance TJ108
Samsung Bioepis Co., Ltd. today announced a strategic, worldwide partnership with Phrontline Biopharma to jointly develop,...